Indivior Plans Cheaper Opioid Addiction Drug if Rivals Launch Copycats Indivior Plans Cheaper Opioid Addiction Drug if Rivals Launch Copycats

December 20, 2018

Indivior Plc said on Tuesday it could launch a cheaper version of its blockbuster opioid addiction treatment, Suboxone, if rivals release generic versions of the drug.Reuters Health Information (Source: Medscape Medical News Headlines) MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% […]

Read the full article →

Indivior plans cheaper opioid addiction drug to keep copycats at bay

December 19, 2018

Indivior Plc said it will launch a cheaper version of its blockbuster opioid addiction treatment, Suboxone, as it seeks to claw back market share lost to copycat versions of the drug. (Source: Reuters: Health)

Read the full article →

Indivior plans cheaper opioid addiction drug if rivals launch copycats

December 19, 2018

Indivior Plc said on Tuesday it could launch a cheaper version of its blockbuster opioid addiction treatment, Suboxone, if rivals release generic versions of the drug. (Source: Reuters: Health) MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

Read the full article →

Buprenorphine-Naloxone Cost-Effective for Opioid Use Disorder

December 18, 2018

MONDAY, Dec. 17, 2018 — Buprenorphine-naloxone is cost-effective compared with extended-release naltrexone for treating opioid use disorder, according to a study published online Dec. 18 in the Annals of Internal Medicine. Sean M. Murphy, Ph.D.,… (Source: Drugs.com – Pharma News) MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log […]

Read the full article →

The Treatment Gap: This City ’ s Overdose Deaths Have Plunged. Can Others Learn From It?

December 12, 2018

Dayton, Ohio, had one of the highest overdose death rates in the nation in 2017. The city made many changes, and fatal overdoses are down more than 50 percent from last year. (Source: NYT Health)

Read the full article →

A Promising Way to Help Drug Users Is ‘Severely Lacking’ Around the World, Report Says

December 12, 2018

Global funding for harm reduction programs is in “crisis,” according to the latest Global State of Harm Reduction report, potentially threatening the effectiveness of HIV, hepatitis and drug overdose relief programs worldwide. Harm reduction policies and programs are meant to curb the negative effects associated with illicit drug use — such as overdoses and the […]

Read the full article →

Indivior says wins fresh hold on Suboxone copy

December 12, 2018

Indivior Plc said on Wednesday a U.S. court ruling had put a hold on Indian rival Dr. Reddy’s Laboratories launching a generic competitor to the London-listed drugmaker’s bestselling opioid addiction treatment. (Source: Reuters: Health)

Read the full article →

Indivior wins fresh hold on Dr. Reddy's Suboxone copy

December 12, 2018

Indivior Plc has secured another hold on the launch of a generic competitor to its best-selling opioid addiction drug in the United States, the London-listed company said on Wednesday. (Source: Reuters: Health) MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

Read the full article →

Dr. Reddy ’s notches win for generic Suboxone sublingual film

November 22, 2018

Shares in Dr. Reddy’s Laboratories (NYSE:RDY) shot up yesterday after the U.S. Court of Appeals for the Federal Circuit vacated a previous decision that blocked the company from selling a generic verson of Indivior‘s (LON:INDV) Suboxone buprenorphine and naloxone sublingual film. Dr. Reddy’s said it plans to resume launch activities for the product, which won FDA approvalin June. Get […]

Read the full article →

U.S. court allows generic version of Indivior opioid abuse drug

November 21, 2018

A U.S. appeals court on Tuesday allowed generic drug company Dr. Reddy’s Laboratories to sell a copycat version of the Indivior Plc opioid treatment Suboxone Film, sending Indivior’s stock price down more than 40 percent. (Source: Reuters: Health) MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with […]

Read the full article →

← Previous Entries

Next Entries →